RECRUITING

BostonGene-Integrated Genomic Registry (BIGR)

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

The purpose of this project is to develop a comprehensive database of genomic, transcriptomic, molecular, and clinical characteristics of oncology patients to discover, define, and develop genomic and transcriptomic markers to improve future clinical outcomes across cancer types

Official Title

BostonGene-Integrated Genomic Registry Study

Quick Facts

Study Start:2021-07-01
Study Completion:2036-07-01
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT04991922

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:18 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:No
Standard Ages:ADULT, OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. 1. Suspected or confirmed malignancy
  2. 2. Planned comprehensive genomic (\> 100 genes) and/or molecular analysis; or genomic and/or molecular data available from prior sequencing
  3. 3. Baseline demographics and treatment information available
  4. 4. Willingness for future contact by BIRG study personnel to provide information regarding associated cancer outcomes and treatment.
  5. 5. Signed informed consent to participate in the study.
  6. 6. Living in the United States at the time of enrollment
  1. Pregnancy or breastfeeding
  2. Severe psychiatric disorders
  3. Active substance abuse
  4. Unstable medical conditions
  5. Inability to comply with study requirements

Contacts and Locations

Study Contact

Nathan Fowler
CONTACT
+1-617-658-4545
nathan.fowler@bostongene.com

Principal Investigator

Nathan Fowler
PRINCIPAL_INVESTIGATOR
BostonGene

Study Locations (Sites)

BostonGene
Waltham, Massachusetts, 02453
United States

Collaborators and Investigators

Sponsor: BostonGene

  • Nathan Fowler, PRINCIPAL_INVESTIGATOR, BostonGene

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2021-07-01
Study Completion Date2036-07-01

Study Record Updates

Study Start Date2021-07-01
Study Completion Date2036-07-01

Terms related to this study

Keywords Provided by Researchers

  • cancer
  • precision medicine
  • WES
  • RNA-seq
  • immuno-therapy
  • genomic
  • transcriptomic
  • multiomic

Additional Relevant MeSH Terms

  • Malignancy